Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

news

a doctor and patient sit on couches talking
News
aLAIs a Useful Treatment Option for Schizophrenia, Study Results Underscore
01/05/2024
Brionna Mendoza
Atypical long-acting injectable (aLAI) antipsychotic medications are useful for the treatment of schizophrenia, especially in patients who experienced persistent psychotic symptoms and had trouble maintaining consistent adherence.
Atypical long-acting injectable (aLAI) antipsychotic medications are useful for the treatment of schizophrenia, especially in patients who experienced persistent psychotic symptoms and had trouble maintaining consistent adherence.
Atypical long-acting injectable...
01/05/2024
Psych Congress Network
Adding Drug-Drug Interactions, Lifestyle Factors Boosts Pharmacogenomics Guidance
News
Adding Drug-Drug Interactions, Lifestyle Factors Boosts Pharmacogenomics Guidance
12/04/2023
Jolynn Tumolo
Incorporating drug-drug interactions and lifestyle factors into pharmacogenomics-guided medication management contributed to improved remission rates in patients with major depressive disorder, according to a poster presentation at Psych...
Incorporating drug-drug interactions and lifestyle factors into pharmacogenomics-guided medication management contributed to improved remission rates in patients with major depressive disorder, according to a poster presentation at Psych...
Incorporating drug-drug...
12/04/2023
Psych Congress Network
stock depression
Conference Poster Highlight
Sleep Disturbances Associated With MDD Recurrence Over 3 Years
10/31/2023
Jolynn Tumolo
Hypersomnolence, insomnia, and sleep dissatisfaction predicted the recurrence of MDD over 3 years, according to a poster presentation at Psych Congress.
Hypersomnolence, insomnia, and sleep dissatisfaction predicted the recurrence of MDD over 3 years, according to a poster presentation at Psych Congress.
Hypersomnolence, insomnia, and...
10/31/2023
Psych Congress Network
schizophrenia treatment
News
TV-46000 Demonstrates Prolonged Schizophrenia Relapse Prevention, SHINE Study Finds
10/25/2023
Meagan Thistle
TV-46000, a long-acting subcutaneous antipsychotic (LASCA), exhibits a favorable long-term benefit-risk profile for patients with schizophrenia, according to study results presented in a poster at Psych Congress 2023.
TV-46000, a long-acting subcutaneous antipsychotic (LASCA), exhibits a favorable long-term benefit-risk profile for patients with schizophrenia, according to study results presented in a poster at Psych Congress 2023.
TV-46000, a long-acting...
10/25/2023
Psych Congress Network
schizophrenia treatment
News
TV-46000 Demonstrates Prolonged Schizophrenia Relapse Prevention, SHINE Study Finds
10/25/2023
Meagan Thistle
TV-46000, a long-acting subcutaneous antipsychotic (LASCA), exhibits a favorable long-term benefit-risk profile for patients with schizophrenia, according to study results presented in a poster at Psych Congress 2023.
TV-46000, a long-acting subcutaneous antipsychotic (LASCA), exhibits a favorable long-term benefit-risk profile for patients with schizophrenia, according to study results presented in a poster at Psych Congress 2023.
TV-46000, a long-acting...
10/25/2023
Psych Congress Network
depression stock photo
Psych Congress Poster Brief
MDD Symptom Improvements With Zuranolone Extend to Daily Lives, Responders Report
10/10/2023
Jolynn Tumolo
Patients with MDD who responded to treatment with zuranolone said they experienced rapid improvement in depressive symptoms and in their daily lives, Psych Congress poster states.
Patients with MDD who responded to treatment with zuranolone said they experienced rapid improvement in depressive symptoms and in their daily lives, Psych Congress poster states.
Patients with MDD who responded...
10/10/2023
Psych Congress Network
News
Viloxazine ER Added to Stimulant Treatment for Pediatric ADHD Appears Safe, Effective
09/09/2023
Jolynn Tumolo
Extended-release viloxazine administered with stimulant medication improved symptoms of ADHD in pediatric patients with an initial inadequate response to stimulant medication, according to a poster presentation at Psych Congress. 
Extended-release viloxazine administered with stimulant medication improved symptoms of ADHD in pediatric patients with an initial inadequate response to stimulant medication, according to a poster presentation at Psych Congress. 
Extended-release viloxazine...
09/09/2023
Psych Congress Network
News
Anhedonia Linked With Worse Depression, Indicating Possible Unmet Need
09/09/2023
Evi Arthur
Higher anhedonia scores were significantly associated with greater levels of depression and anxiety in adults with MDD, according to a poster presentation at Psych Congress 2023 in Nashville, Tennessee.
Higher anhedonia scores were significantly associated with greater levels of depression and anxiety in adults with MDD, according to a poster presentation at Psych Congress 2023 in Nashville, Tennessee.
Higher anhedonia scores were...
09/09/2023
Psych Congress Network
Christine Moutier, MD, Chief Medical Officer for the American Foundation for Suicide Prevention (AFSP).
News
Transformative ‘Talk Therapy:’ Psych Congress Keynote Considers Medicinal Music
09/07/2023
Brionna Mendoza
The 36th Annual Psych Congress meeting convened on Wednesday, September 6th, in Nashville, Tennessee, with a robust pre-conference program that concluded with the second-ever Eric C. Arauz Memorial Keynote Address.
The 36th Annual Psych Congress meeting convened on Wednesday, September 6th, in Nashville, Tennessee, with a robust pre-conference program that concluded with the second-ever Eric C. Arauz Memorial Keynote Address.
The 36th Annual Psych Congress...
09/07/2023
Psych Congress Network
Psych Congress Partners With AFSP to Enhance Mental Health Education and Community Support
News
Psych Congress Partners With AFSP to Enhance Mental Health Education and Community Support
09/05/2023
Meagan Thistle
HMP Global, a health care events and education company, has unveiled an expanded partnership between the annual Psych Congress national meeting and the American Foundation for Suicide Prevention (AFSP).
HMP Global, a health care events and education company, has unveiled an expanded partnership between the annual Psych Congress national meeting and the American Foundation for Suicide Prevention (AFSP).
HMP Global, a health care events...
09/05/2023
Psych Congress Network

Advertisement

About

Celebrating 35 years of empowering the highest standard in mental healthcare, Psych Congress serves as a unique, integrated forum to connect members of the entire mental health team—bringing together psychiatrists, nurse practitioners, physician assistants, psychologists, primary care physicians, and other mental health professionals for 4 days of practical education to improve patient care.

Advertisement

May 30 ⁠–⁠ June 1
May 30 ⁠–⁠ June 2
Psych Congress Regionals
June 20 ⁠–⁠ June 21
Psych Congress Regionals
July 18 ⁠–⁠ July 19
Psych Congress Regionals
August 8 ⁠–⁠ August 9
August 16 ⁠–⁠ August 18
Cape Cod Symposium
September 5 ⁠–⁠ September 8
Psych Congress Regionals
September 12 ⁠–⁠ September 13
October 29 ⁠–⁠ November 2
ECS
November 8 ⁠–⁠ November 10
See Full Calendar

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use